“Tissue Healing Research in-flight Viability Experiment” (THRIVE) is a validation experiment designed to investigate a transport module for organic and inorganic components of the novel wound healing method StellarHeal under extreme conditions.

The experiment aims to validate the functionality of the actively cooled transport module while simultaneously assessing the resilience of the wound healing components developed by the Fraunhofer ISC during a REXUS flight as a secondary objective. The experiment module protects the sensitive organic components from external thermal influences, records acceleration and temperature changes and facilitates the analysis of potential damage to the stem cells after recovery.

The knowledge gained through THRIVE will form the basis for the future use of StellarHeal wound healing in manned space flight.

Learn more about the REXUS/BEXUS program

Sketch of the THRIVE transport module
Figure 1: Side View of the actively cooled transport module
Image
Figure 2: Thrive Software and Hardware Development
Image
Figure 3: CAD Model of the final assembly

Timeline

4-6 Jun 2025 – REXUS Critical Design Reviews (CDRs), DLR Oberpfaffenhofen

Aug 2025 – REXUS Integration Progress Reviews (IPRs) at student team sites

Nov 2025 – REXUS Experiment Acceptance Reviews (EARs) at student team sites

8-12 Dec 2025 – Integration Week (ITW), ZARM-FAB Bremen

12-16 Jan 2026 – Bench Test, DLR Oberpfaffenhofen

2-14 Mar 2026 – REXUS Campaign (12 days), SSC, Esrange Space Center

Jun 2026 – Delivery of the final REXUS Experiments reports

Image